Problems and Countermeasures Faced by Pharmaceutical Companies in the Context of Homogeneous Competition

DOI

10.2991/aebmr.k.220405.103How to use a DOI?

Keywords

Homogenization; Pharmaceutical Companies; Development Analysis

Abstract

With the progress of biotechnology and the rise of health industry, pharmaceutical companies are developing in good prospect. However, many pharmaceutical companies are facing new challenges in the context of homogenization. There have been many scholars who have explored the homogenization in other fields and the development strategies of pharmaceutical companies deeply, but there are fewer case studies that combine the dual factors. Based on literature reading, this paper adopts the case study method and roots in coding to study representative pharmaceutical enterprises, analyze the common problems of pharmaceutical enterprises based on the background of homogenization and propose corresponding countermeasures for the current situation, to help pharmaceutical enterprises continue to innovate and breakthrough in the fierce competition, thus promoting the iterative upgrading of the whole industry.

Copyright

© 2022 The Authors. Published by Atlantis Press International B.V.

Open Access

This is an open access article distributed under the CC BY-NC 4.0 license.

Download article (PDF)

TY  - CONF
AU  - Xinzhi Hu
PY  - 2022
DA  - 2022/04/29
TI  - Problems and Countermeasures Faced by Pharmaceutical Companies in the Context of Homogeneous Competition
BT  - Proceedings of the 2022 7th International Conference on Social Sciences and Economic Development (ICSSED 2022)
PB  - Atlantis Press
SP  - 624
EP  - 629
SN  - 2352-5428
UR  - https://doi.org/10.2991/aebmr.k.220405.103
DO  - 10.2991/aebmr.k.220405.103
ID  - Hu2022
ER  -